Adamas Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Adamas Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 36% to $74,461,000. The net income raised on -$57,403,000 and profit margin reached -77%. Total operating expenses were $116,587,000.
Profit Margin
| 2012 | 37.47M | 17.73M | 47.33% |
|---|---|---|---|
| 2013 | 71.09M | 50.92M | 71.62% |
| 2014 | 55.84M | 10.22M | 18.31% |
| 2015 | 1.91M | -51.80M | -2703.65% |
| 2016 | 572K | -60.05M | -10499.65% |
| 2017 | 571K | -89.49M | -15672.5% |
| 2018 | 34.04M | -130.99M | -384.77% |
| 2019 | 54.63M | -105.18M | -192.52% |
| 2020 | 74.46M | -57.40M | -77.09% |
ADMS Income Statement (2012 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 74.46M | 54.63M | 34.04M | 571K | 572K | 1.91M | 55.84M | 71.09M | 37.47M |
Cost of revenue | 2.03M | 2.46M | 633K | 17K | 0 | 0 | 0 | 0 | 0 |
Gross profit | 72.42M | 52.16M | 33.41M | 554K | 572K | 1.91M | 55.84M | 71.09M | 37.47M |
Operating exp. | |||||||||
Research and development | 9.74M | 30.03M | 39.3M | 27.16M | 31.23M | 35.89M | 21.86M | 7.41M | 9.19M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 116.58M | 144.40M | 148.43M | 88.48M | 61.55M | 59.35M | 37.33M | 14.07M | 17.52M |
Operating income | -44.16M | -92.23M | -115.02M | -87.92M | -60.98M | -57.43M | 18.51M | 57.01M | 19.94M |
Other income (expenses), net | -13.23M | -12.95M | -15.97M | -3.29M | 811K | 363K | -917K | -4.90M | -1.91M |
Income before tax | -57.40M | -105.18M | -130.99M | -91.22M | -60.17M | -57.07M | 17.59M | 52.11M | 18.03M |
Income tax expense | 0 | 2.09M | 3.11M | -1.73M | -115K | -5.27M | 7.37M | 1.19M | 300K |
Net income | -57.40M | -105.18M | -130.99M | -89.49M | -60.05M | -51.80M | 10.22M | 50.92M | 17.73M |
Earnings per share | |||||||||
Basic EPS | -1.63 | -3.8 | -4.87 | -3.97 | -2.77 | -2.86 | 0.69 | 3.8 | 1.20 |
Diluted EPS | -1.63 | -3.8 | -4.87 | -3.97 | -2.77 | -2.86 | 0.6 | 3.22 | 0.98 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |